The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development

Developmental Biology

Volumn 369, Issue 2, 2012, Pages 249-260

  Verma, Suman ^a   Salmans, Michael L ^a   Geyfman, Mikhail ^a   Wang, Hong ^a   Yu, Zhengquan ^a,c   Lu, Zhongxian ^a,d   Zhao, Fang ^b   Lipkin, Steven M ^b   Andersen, Bogi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

^d XIAMEN UNIVERSITY   (China)

Author keywords

Agr2; Development; Estrogen responsive; Knockout; Mammary gland; Overexpression; Proliferation

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MILK PROTEIN; PROTEIN AGR2; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

AGR2 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION REGULATION; LACTATION; LOBULOALVEOLAR DEVELOPMENT; MAMMARY GLAND; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUERPERIUM;

EID: 84865196885     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.06.030     Document Type: Article

References (50)

1. Aberger F., et al. Anterior specification of embryonic ectoderm: the role of the xenopus cement gland-specific gene XAG-2. Mech. Dev. 1998, 72:115-130.
2. Barraclough D.L., et al. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am. J. Pathol. 2009, 175:1848-1857.
3. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
4. Bocchinfuso W.P., et al. Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 2000, 141:2982-2994.
5. Brychtova V., et al. Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett. 2011, 304:1-7.
6. Bu H., et al. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 2011, 71:575-587.
7. Dong A., et al. The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J. Biol. Chem. 2011, 286:18301-18310.
8. Dorssers L.C., et al. Tamoxifen resistance in breast cancer: elucidating mechanisms. Drugs 2001, 61:1721-1733.
9. Dumartin L., et al. AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res. 2011, 71:7091-7102.
10. Fata J.E., et al. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 2004, 6:1-11.
11. Fletcher G.C., et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br. J. Cancer 2003, 88:579-585.
12. Fritzsche F.R., et al. Expression of AGR2 in non small cell lung cancer. Histol. Histopathol. 2007, 22:703-708.
13. Fritzsche F.R., et al. Prognostic relevance of AGR2 expression in breast cancer. Clin. Cancer Res. 2006, 12:1728-1734.
14. Fullwood M.J., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
15. Furth P.A., et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. PNAS 1994, 91:9302-9306.
16. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. PNAS 1992, 89:5547-5551.
17. Gunther E.J., et al. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 2002, 16:283-292.
18. Higa A., et al. Role of the pro-oncogenic Protein Disulfide Isomerase (PDI)-family member Anterior Gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. J. Biol. Chem. 2011, 286:44855-44868.
19. Hrstka R., et al. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene 2010, 29:4838-4847.
20. Innes H.E., et al. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br. J. Cancer 2006, 94:1057-1065.
21. Kistner A., et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. PNAS 1996, 93:10933-10938.
22. Liu D., et al. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res. 2005, 65:3796-3805.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
24. Maresh E.L., et al. Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer 2010, 10:680.
25. Maslon M.M., et al. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for reptin. J. Mol. Biol. 2010, 404:418-438.
26. Munoz B., Bolander F.F. Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium. Mol. Cell. Endocrinol. 1989, 62:23-29.
27. Olsson H., et al. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res. Treat. 1996, 40:187-196.
28. Park K., et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp. Mol. Med. 2011, 43:91-100.
29. Park S.W., et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. PNAS 2009, 106:6950-6955.
30. Persson S., et al. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol. Phylogenet. Evol. 2005, 36:734-740.
31. Pizzi M., et al. Anterior gradient 2 overexpression in lung adenocarcinoma. Appl. Immunohistochem. Mol. Morphol. 2012, 20:31-36.
32. Pohler E., et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol. Cell. Proteomics 2004, 3:534-547.
33. Ramachandran V., et al. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008, 68:7811-7818.
34. Riener M.O., et al. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histol. Histopathol. 2009, 24:1121-1128.
35. Ross-Innes C.S., et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393.
36. Shyamala G., et al. Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging. J. Steroid Biochem. Mol. Biol. 2002, 80:137-148.
37. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
38. Sternlicht M.D., et al. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 2005, 132:3923-3933.
39. Thompson D.A., Weigel R.J. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem. Biophys. Res. Commun. 1998, 251:111-116.
40. Vanderlaag K.E., et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res. 2010, 12:R32.
41. Vivekanandan P., et al. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum. Pathol. 2009, 40:293-299.
42. Wagner K.U., et al. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res. 2001, 10:545-553.
43. Wagner K.U., et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 1997, 25:4323-4330.
44. Wang N., et al. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 2007, 26:6431-6441.
45. Wang Z., et al. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008, 68:492-497.
46. Whisenhunt T.R., et al. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 2006, 16:551-563.
47. Wu Z.S., et al. Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance. Zhonghua Bing Li Xue Za Zhi 2008, 37:109-113.
48. Zeps N., et al. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation 1998, 62:221-226.
49. Zhang J.S., et al. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005, 43:249-259.
50. -/- mice. Dev. Biol. 2010, 338:270-279.